Table 2.
Screen | Baseline | Operative | 3 months | 12 months | |
---|---|---|---|---|---|
UDI | ✓ | ✓ | ✓ | ||
PGI-I | ✓ | ✓ | |||
PGI-S | ✓ | ✓ | ✓ | ||
Stress Test | ✓ | ✓ | |||
UDS | ✓ | ||||
Additional Treatment | ✓ | ✓ | |||
SF-12 | ✓ | ✓ | ✓ | ||
IIQ-7 | ✓ | ✓ | ✓ | ||
ISI | ✓ | ✓ | ✓ | ||
MESA | ✓ | ✓ | ✓ | ||
Voiding Function | ✓ | ✓ | |||
Patient Satisfaction | ✓ | ✓ | |||
Patient Preparedness | ✓ | ||||
Adverse Events | ✓ | ✓ | ✓ | ✓ | |
Urine Dipstick | ✓ | ||||
Costs & Utilities | ✓ | ✓ | |||
Sociodemographic | ✓ | ||||
Comorbidities | ✓ | ✓ | ✓ | ||
H&P | ✓ | ✓ | ✓ | ||
PVR | ✓ | ✓ | |||
Medication Audit | ✓ | ✓ | ✓ | ||
Prolapse Assessment | ✓ | ||||
Urethral Mobility | ✓ | ||||
Operative Measures | ✓ | ||||
MD Dx & Tx Info. | ✓ | ✓ | ✓ | ✓ |
UDI-Urogenital Distress Inventory[10]; PGI-I- Patient Global Impression of Improvement[11–13]; PGI-S-Patient Global Impression of Severity [11–13]; UDS-Urodynamics; SF-12-Short Form-12; IIQ-7-Incontinence Impact Questionnaire-7; ISI-Incontinence Severity Index[15]; MESA-Medical and social Aspects of Aging questionnaire[14]; H&P- History and Physical; PVR- Post void residual volume; MD Dx- Physician diagnosis; Tx Info- Treatment information.